These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 9685906)

  • 1. Validation and testing of a new iontophoretic continuous flow through transport cell.
    van der Geest R; Danhof M; Boddé HE
    J Control Release; 1998 Jan; 51(1):85-91. PubMed ID: 9685906
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Compartmental modeling of transdermal iontophoretic transport: I. In vitro model derivation and application.
    Nugroho AK; Della Pasqua O; Danhof M; Bouwstra JA
    Pharm Res; 2004 Nov; 21(11):1974-84. PubMed ID: 15587918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transdermal iontophoresis of rotigotine across human stratum corneum in vitro: influence of pH and NaCl concentration.
    Nugroho AK; Li GL; Danhof M; Bouwstra JA
    Pharm Res; 2004 May; 21(5):844-50. PubMed ID: 15180344
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Iontophoretic delivery of apomorphine. I: In vitro optimization and validation.
    van der Geest R; Danhof M; Boddé HE
    Pharm Res; 1997 Dec; 14(12):1798-803. PubMed ID: 9453071
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro iontophoresis of R-apomorphine across human stratum corneum. Structure-transport relationship of penetration enhancement.
    Li GL; van der Geest R; Chanet L; van Zanten E; Danhof M; Bouwstra JA
    J Control Release; 2002 Nov; 84(1-2):49-57. PubMed ID: 12399167
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iontophoretic R-apomorphine delivery in combination with surfactant pretreatment: in vitro validation studies.
    Li GL; Grossklaus A; Danhof M; Bouwstra JA
    Int J Pharm; 2003 Nov; 266(1-2):61-8. PubMed ID: 14559394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pretreatment with a water-based surfactant formulation affects transdermal iontophoretic delivery of R-apomorphine in vitro.
    Li GL; Danhof M; Frederik PM; Bouwstra JA
    Pharm Res; 2003 Apr; 20(4):653-9. PubMed ID: 12739775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined chemical and electrical enhancement modulates stratum corneum structure.
    de Graaff AM; Li GL; van Aelst AC; Bouwstra JA
    J Control Release; 2003 Jun; 90(1):49-58. PubMed ID: 12767706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iontophoretic delivery of apomorphine: from in-vitro modelling to the Parkinson patient.
    Junginger HE
    Adv Drug Deliv Rev; 2002 Nov; 54 Suppl 1():S57-75. PubMed ID: 12460716
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of appendages in skin resistance and iontophoretic peptide flux: human versus snake skin.
    Craane-van Hinsberg WH; Verhoef JC; Bax LJ; Junginger HE; Boddé HE
    Pharm Res; 1995 Oct; 12(10):1506-12. PubMed ID: 8584490
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lontophoretic delivery of apomorphine in vitro: physicochemic considerations.
    Li GL; Danhof M; Bouwstra JA
    Pharm Res; 2001 Nov; 18(11):1509-13. PubMed ID: 11758756
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal iontophoresis of the dopamine agonist 5-OH-DPAT in human skin in vitro.
    Nugroho AK; Li L; Dijkstra D; Wikström H; Danhof M; Bouwstra JA
    J Control Release; 2005 Mar; 103(2):393-403. PubMed ID: 15763622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iontophoretic delivery of apomorphine. II: An in vivo study in patients with Parkinson's disease.
    van der Geest R; van Laar T; Gubbens-Stibbe JM; Boddé HE; Danhof M
    Pharm Res; 1997 Dec; 14(12):1804-10. PubMed ID: 9453072
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of elastic liquid-state vesicle on apomorphine iontophoresis transport through human skin in vitro.
    Li GL; Danhof M; Bouwstra JA
    Pharm Res; 2001 Nov; 18(11):1627-30. PubMed ID: 11758773
    [No Abstract]   [Full Text] [Related]  

  • 15. Convective solvent flow across the skin during iontophoresis.
    Kim A; Green PG; Rao G; Guy RH
    Pharm Res; 1993 Sep; 10(9):1315-20. PubMed ID: 8234169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal iontophoretic delivery of apomorphine in patients improved by surfactant formulation pretreatment.
    Li GL; de Vries JJ; van Steeg TJ; van den Bussche H; Maas HJ; Reeuwijk HJ; Danhof M; Bouwstra JA; van Laar T
    J Control Release; 2005 Jan; 101(1-3):199-208. PubMed ID: 15588905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transport mechanisms in iontophoresis. III. An experimental study of the contributions of electroosmotic flow and permeability change in transport of low and high molecular weight solutes.
    Pikal MJ; Shah S
    Pharm Res; 1990 Mar; 7(3):222-9. PubMed ID: 2339093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Scanning electrochemical microscopy of iontophoretic transport in hairless mouse skin. Analysis of the relative contributions of diffusion, migration, and electroosmosis to transport in hair follicles.
    Bath BD; Scott ER; Phipps JB; White HS
    J Pharm Sci; 2000 Dec; 89(12):1537-49. PubMed ID: 11042601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transdermal iontophoresis of rotigotine: influence of concentration, temperature and current density in human skin in vitro.
    Nugroho AK; Li G; Grossklaus A; Danhof M; Bouwstra JA
    J Control Release; 2004 Apr; 96(1):159-67. PubMed ID: 15063038
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iontophoretic delivery of 5-aminolevulinic acid and its methyl ester using a carbopol gel as vehicle.
    Merclin N; Bramer T; Edsman K
    J Control Release; 2004 Jul; 98(1):57-65. PubMed ID: 15245889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.